Aethlon Medical, Inc. (NASDAQ:AEMD) Stock Short Interest Report for October

by · The Cerbat Gem

Aethlon Medical, Inc. (NASDAQ:AEMD – Get Free Report) was the recipient of a large decline in short interest in October. As of October 15th, there was short interest totaling 32,925 shares, a decline of 56.4% from the September 30th total of 75,446 shares. Currently, 4.7% of the shares of the stock are short sold. Based on an average trading volume of 57,317 shares, the short-interest ratio is presently 0.6 days.

Analyst Ratings Changes

AEMD has been the subject of a number of recent analyst reports. HC Wainwright reiterated a “neutral” rating on shares of Aethlon Medical in a research report on Friday, September 18th. Wall Street Zen upgraded Aethlon Medical to a “sell” rating in a research report on Saturday, October 17th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Aethlon Medical in a research note on Thursday, October 15th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus price target of $1.50.

Get Our Latest Stock Report on Aethlon Medical

Aethlon Medical Trading Down 1.4%

NASDAQ AEMD traded down $0.08 during trading on Friday, hitting $5.44. 27,667 shares of the company’s stock were exchanged, compared to its average volume of 59,298. The company has a market cap of $3.86 million, a PE ratio of -0.16 and a beta of 1.21. Aethlon Medical has a fifty-two week low of $1.41 and a fifty-two week high of $26.90. The stock’s 50 day moving average price is $4.47 and its two-hundred day moving average price is $7.79.

Aethlon Medical (NASDAQ:AEMD – Get Free Report) last posted its quarterly earnings results on Thursday, August 13th. The medical equipment provider reported ($4.02) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.92) by ($0.10). Analysts forecast that Aethlon Medical will post -5.74 earnings per share for the current fiscal year.

About Aethlon Medical

(Get Free Report)

Aethlon Medical, Inc is a biotechnology and medical-device company focused on developing extracorporeal blood filtration technologies for life-threatening diseases. The company’s lead product candidate, the Hemopurifier, is designed to selectively remove harmful substances from the bloodstream, including cancer-promoting exosomes and certain viral particles.

The Hemopurifier is intended to be used with standard dialysis or blood-circulation equipment and is being investigated for potential applications in oncology and infectious disease.

Further Reading